Weekly News – November 17
Meet our 2023 Sponsors
2024 Sponsorships Now Available
CRC Allocators Conference:
Andrew Herenstein of Monarch on Opportunity Set
Click on the screenshot to play the video
Name that tune!
Celsius getting out of dodge!
Make-wholes faring well
The latest abusive trend or creative financing?
Tell us what you think here
Puerto Rico still a dogfight
Tehum gets new mediator
Inflation coming down
but higher rates pressuring credit
What we’re reading
Thank you for Inviting the CRC to the Beard Investing Conference
Thank you for making the
CRC Allocators Conference
CRC weighs in on Serta
The Academics Speak Up
Purdue Pharma is the gift that keeps on giving. This is our third installment on the twists and turns this case has taken through the Courts. You can read our first installment here, and our second here.
All bets came off the table when the Supreme Court decided to reshuffle the deck by taking on the appeal of the 2nd Circuit’s decision. Not only did SCOTUS take the unusual step of taking on this big ticket issue in BK cases but it also stopped the lower court’s decision in its tracks putting the breaks on the entire enchilada. We decided to consult with our expert Academic Contributors for our inaugural feature the Academics Speak Up to get their takes on the latest developments.
We are excited to bring you the varying perspectives of Prof. Tony Casey, Prof. Samir Parikh and Prof. Ralph Brubaker.
Read more on Purdue Pharma
click through to read the features from our Contributors
Read our recent coverage:
Where Are We In The Credit Cycle?
Look out for more great features from our Contributors
Have something interesting to share?
email us at [email protected]